Prevalence of Sexually Transmitted Infections and Human Immunodeficiency Virus in Transgender Persons: A Systematic Review

التفاصيل البيبلوغرافية
العنوان: Prevalence of Sexually Transmitted Infections and Human Immunodeficiency Virus in Transgender Persons: A Systematic Review
المؤلفون: Karen Musgrove, Christina A. Muzny, Dustin M. Long, Aditi Jani, Olivia T Van Gerwen, Erika L. Austin
المصدر: Transgender Health
بيانات النشر: Mary Ann Liebert Inc, 2020.
سنة النشر: 2020
مصطلحات موضوعية: medicine.medical_specialty, Gonorrhea, Population, Reviews, Medicine (miscellaneous), urologic and male genital diseases, Gender Studies, Acquired immunodeficiency syndrome (AIDS), Epidemiology, Transgender, medicine, education, sexually transmitted infections, education.field_of_study, Trichomoniasis, Chlamydia, business.industry, virus diseases, medicine.disease, transgender, female genital diseases and pregnancy complications, Family medicine, HIV/AIDS, epidemiology, Syphilis, business
الوصف: Purpose: Despite reportedly high rates of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs) among transgender people, laboratory-proven prevalence of these infections in this population has not been systematically reviewed. We performed a systematic review and meta-analysis of the medical literature involving laboratory-proven HIV and STI diagnoses among transgender people. Methods: A systematic review of the English literature regarding laboratory-proven HIV and/or STI testing in transgender populations within the last 50 years was performed. Preliminary meta-analyses assessing the prevalence of HIV and STIs among both transgender men and transgender women were performed. Given the heterogeneity of included studies, these analyses were difficult to interpret and not included in our results. Results: Our literature review identified 25 studies, representing 11 countries. All of these studies included transgender women, with 9 (36%) including data on transgender men. HIV was the most commonly studied STI, with prevalence ranging from 0% to 49.6% in transgender women and 0% to 8.3% in transgender men. For syphilis, gonorrhea, and chlamydia, respectively, prevalence ranged from 1.4% to 50.4%, 2.1% to 19.1%, and 2.7% to 24.7% in transgender women and from 0% to 4.2%, 0% to 10.5%, and 1.2% to 11.1% in transgender men. Site-specific testing practices for gonorrhea and chlamydia were variable. No studies reported prevalence data on trichomoniasis. Conclusion: The literature describing STIs and transgender people primarily focuses on transgender women and HIV. Data involving HIV and STIs among transgender men are lacking. These findings highlight opportunities for the future study of epidemiology of HIV/STIs in transgender men and the relevance of STIs in transgender people.
تدمد: 2380-193X
2688-4887
DOI: 10.1089/trgh.2019.0053
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d26d11a4af5b5da6ff982a29ddcb86b7
https://doi.org/10.1089/trgh.2019.0053
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....d26d11a4af5b5da6ff982a29ddcb86b7
قاعدة البيانات: OpenAIRE
الوصف
تدمد:2380193X
26884887
DOI:10.1089/trgh.2019.0053